DAIC

MARCH 27, 2024

The company reports this broadens the use of the novel bioadaptor platform technology beyond the treatment of coronary artery disease. The DynamX Bioadaptor platform is a medical technology designed to establish the new standard of care for vascular interventions, according to a written statement on the designation.

Peripheral Arterial Disease 111

Peripheral Arterial Disease Ischemia Technology Coronary Artery Disease 111

DAIC

NOVEMBER 8, 2024

THOR IDE clinical trial, which will study an innovative combined laser atherectomy and intravascular lithotripsy catheter that integrates two critical PAD treatments into a single device. The care team there successfully treated a 78-year-old male with peripheral vascular disease using the Philips device.

Innovation 52

Innovation Peripheral Arterial Disease Technology Ultrasound 52

DAIC

MARCH 20, 2024

CLTI is the most severe form of peripheral arterial disease (PAD), estimated to affect 11% of the 200 million people suffering from PAD globally. degradation of magnesium observed 12 months after implantation in coronary arteries.4 2,3 It has shown 99.6%

Peripheral Arterial Disease 105

Peripheral Arterial Disease Innovation Technology Coronary Artery Disease 105

DAIC

MAY 31, 2024

Joaquin Duato , Chairman and Chief Executive Officer of Johnson & Johnson, said, “Through Innovative Medicine and MedTech, Johnson & Johnson is transforming the trajectory of cardiovascular disease, one of the leading causes of death globally.

Peripheral Arterial Disease 104

Peripheral Arterial Disease Innovation Coronary Artery Disease Cardiovascular Interventions 104

DAIC

APRIL 5, 2024

With the addition of Shockwave, Johnson & Johnson will expand its MedTech cardiovascular portfolio into two of the highest-growth, innovation-oriented segments of cardiovascular intervention – coronary artery disease (CAD) and peripheral artery disease (PAD).

Cardiovascular Interventions 105

Cardiovascular Interventions Technology Innovation Angina 105

DAIC

JUNE 4, 2024

a vascular surgeon and director of HonorHealth’s vascular services, said the device avoids carotid endarterectomy, a previous method for removing plaque from carotid arteries, which involves a surgical procedure requiring an incision directly into the neck. We were fortunate to be the first in the Southwest to use such technology.”

Stents 111

Stents Stent Research Stroke 111

DAIC

JUNE 18, 2024

The designation recognizes the novelty of the technology and the potential to provide a more effective treatment option for patients with coronary artery disease. 1 To date, interventional treatment of coronary artery disease with drug-eluting stents has been able to establish flow angiographically. of the U.S.

Coronary Artery Disease 105

Coronary Artery Disease Technology Stents Stent 105